The acquisition will combine Buxco’s expertise in preclinical pulmonary research with DSI’s leadership in designing and manufacturing implantable telemetry devices to provide researchers a world class physiologic monitoring solution. Read more.
Efficient microRNA inhibition in a highly invasive orthotopic glioblastoma model » The Impact of Voluntary Exercise on Stress-Induced Disruptions in Diurnal Rhythms of Sleep and Physiology » Best practices for performing experimental surgery in swine. »
Novel technology for modulating locomotor activity as an operant response in the mouse: Implications for neuroscience studies involving “exercise” in rodents. »